Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Vaccine Production01:23

Vaccine Production

61
Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...
61
Vaccinations01:51

Vaccinations

54.0K
Overview
54.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Feasibility and optimization of a novel, cranially-mounted deep brain stimulation device for children with epilepsy - the CADET Pilot study.

Brain stimulation·2026
Same author

Application of Electric-Field-Optimized Augmented Reality-Guided Neuronavigation in Transcranial Magnetic Stimulation.

Journal of clinical medicine·2026
Same author

Repetitive transcranial magnetic stimulation as adjunctive therapy in adult patients with drug-resistant epilepsy-A systematic review and meta-analysis.

Epileptic disorders : international epilepsy journal with videotape·2026
Same author

PARP inhibition generates enhanced CD8<sup>+</sup> central memory T cells by transcriptional and metabolic reprogramming.

Nature immunology·2026
Same author

Electrical Cortical Stimulation for Language Mapping in Epilepsy Surgery-A Systematic Review.

Brain sciences·2025
Same author

Seizure forecasting by tracking cortical response to electrical stimulation.

Epilepsia·2025

Related Experiment Video

Updated: Apr 4, 2026

Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches
13:36

Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches

Published on: May 6, 2015

10.9K

HIV DNA Vaccine: Stepwise Improvements Make a Difference.

Barbara K Felber1, Antonio Valentin2, Margherita Rosati3

  • 1Human Retrovirus Pathogenesis Section, Vaccine Branch, Center for Cancer Research, National Cancer Institute at Frederick, P.O. Box B, Frederick, MD 21702, USA. barbara.felber@nih.gov.

Vaccines
|September 8, 2015
PubMed
Summary
This summary is machine-generated.

DNA vaccines offer a promising, safe, and effective platform against HIV/AIDS. Advances in DNA vaccine technology over 30 years have overcome previous delivery and expression challenges, paving the way for clinical application.

Keywords:
DNA deliveryDNA expressioncytokineelectroporationimmunogenicitymacaqueplasmidvaccination

More Related Videos

Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation
10:58

Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation

Published on: August 21, 2019

8.1K
Interview: HIV-1 Proviral DNA Excision Using an Evolved Recombinase
10:20

Interview: HIV-1 Proviral DNA Excision Using an Evolved Recombinase

Published on: June 16, 2008

11.8K

Related Experiment Videos

Last Updated: Apr 4, 2026

Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches
13:36

Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches

Published on: May 6, 2015

10.9K
Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation
10:58

Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation

Published on: August 21, 2019

8.1K
Interview: HIV-1 Proviral DNA Excision Using an Evolved Recombinase
10:20

Interview: HIV-1 Proviral DNA Excision Using an Evolved Recombinase

Published on: June 16, 2008

11.8K

Area of Science:

  • Immunology
  • Vaccinology
  • Molecular Biology

Background:

  • Plasmid DNA vaccines face challenges in efficient delivery and low expression, hindering their use against HIV/AIDS.
  • Overcoming these obstacles is crucial for developing effective AIDS vaccines.

Purpose of the Study:

  • To review advancements in DNA vaccine methodology over the past three decades.
  • To highlight the potential of DNA vaccination as a rapid, safe, and effective vaccine platform for HIV/AIDS.

Main Methods:

  • Review of scientific literature on DNA vaccine development.
  • Analysis of strategies to improve DNA delivery and plasmid expression.
  • Examination of clinical trial data for DNA vaccines against AIDS.

Main Results:

  • Significant progress has been made in enhancing DNA vaccine efficacy.
  • Combination approaches, alongside improved methods, show promise.
  • Recent clinical trials indicate feasibility for translation into the clinic.

Conclusions:

  • DNA vaccination, alone or in combination, presents a viable strategy for an AIDS vaccine.
  • Continued research and development are essential for realizing the full potential of DNA vaccines.
  • Clinical trial outcomes support the advancement of DNA vaccine technology for HIV/AIDS prevention.